Stereotactic Versus Conventional Radiotherapy in Medically Inoperable Stage I Non-Small Cell Lung Cancer: A Bayesian Reanalysis of the LUSTRE Randomized Trial.

Wang Y, Donovan EK, Levine MN, Whelan TJ, Swaminath A, Parpia S, LUSTRE Trial Investigators

Open source

DOI
10.1016/j.cllc.2026.03.008
Published
2026 May
Container
Clinical lung cancer
Publisher
Not recorded
Open access
no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.cllc.2026.03.008,
  title = {Stereotactic Versus Conventional Radiotherapy in Medically Inoperable Stage I Non-Small Cell Lung Cancer: A Bayesian Reanalysis of the LUSTRE Randomized Trial.},
  author = {Wang Y and Donovan EK and Levine MN and Whelan TJ and Swaminath A and Parpia S and LUSTRE Trial Investigators},
  year = {2026},
  journal = {Clinical lung cancer},
  doi = {10.1016/j.cllc.2026.03.008},
  url = {https://doi.org/10.1016/j.cllc.2026.03.008}
}

RIS

TY  - JOUR
TI  - Stereotactic Versus Conventional Radiotherapy in Medically Inoperable Stage I Non-Small Cell Lung Cancer: A Bayesian Reanalysis of the LUSTRE Randomized Trial.
AU  - Wang Y
AU  - Donovan EK
AU  - Levine MN
AU  - Whelan TJ
AU  - Swaminath A
AU  - Parpia S
AU  - LUSTRE Trial Investigators
PY  - 2026
JO  - Clinical lung cancer
DO  - 10.1016/j.cllc.2026.03.008
UR  - https://doi.org/10.1016/j.cllc.2026.03.008
ER  - 

APA

Y, W., EK, D., MN, L., TJ, W., A, S., S, P., & Investigators, L. T. (2026). Stereotactic Versus Conventional Radiotherapy in Medically Inoperable Stage I Non-Small Cell Lung Cancer: A Bayesian Reanalysis of the LUSTRE Randomized Trial.. Clinical lung cancer. https://doi.org/10.1016/j.cllc.2026.03.008

Source records